Process for the preparation of alpha form of imatinib mesylate

Details for Australian Patent Application No. 2011213936 (hide)

Owner Reliance Life Sciences Pvt. Ltd. Ashwani, S.

Inventors Ashwani, Sharma; Chandrabhan, Madhav Hire; Rohit, Chaturvedi; Rajan, Gupte

Agent Wrays

Pub. Number AU-A-2011213936

PCT Pub. Number WO2011/099039

Priority 398/MUM/2010 15.02.10 IN

Filing date 15 February 2011

Wipo publication date 18 August 2011

International Classifications

C07D 401/04 Heterocyclic compounds containing two or more hetero rings

A61K 31/506 - not condensed and containing further heterocyclic rings

A61P 35/00 Antineoplastic agents

Event Publications

6 September 2012 PCT application entered the National Phase

  PCT publication WO2011/099039 Priority application(s): WO2011/099039

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011213944-Salts and polymorphs of 8-fluoro-2-{4- [(methylamino}methyl]phenyl}-1,3,4,5tetrahydro-6H-azepino[5,4,3-cd]indol-6one

2011213923-Diagnosis of systemic lupus erythematosus (SLE)